Italy Oligonucleotide Synthesis Market Size & Outlook
The oligonucleotide synthesis market in Italy is expected to reach a projected revenue of US$ 243.1 million by 2033. A compound annual growth rate of 13.5% is expected of Italy oligonucleotide synthesis market from 2026 to 2033.
Thermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc Common Stock, Agilent Technologies, Kaneka Corp, Heritage Global Inc, Twist Bioscience Corp, Bio-Synthesis, Biolegio
Other key industry trends
In terms of revenue, Italy accounted for 2.5% of the global oligonucleotide synthesis market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Europe, Germany oligonucleotide synthesis market is projected to lead the regional market in terms of revenue in 2033.
UK is the fastest growing regional market in Europe and is projected to reach USD 708.0 million by 2033.
. The same source stated that R&D investments in biotechnology sector involves 13,277 employees in biotech research. Hence, the increasing research investments and initiatives in the country are anticipated to boost the demand for advanced oligonucleotide synthesis for research applications.
In addition, key players in this market are adopting various strategies, which are expected to support market growth. For instance, in February 2022, Macrogen Europe BV opened the Milan Genome Center in Italy. This center is focused on oligo synthesis, microsatellite analysis, Sanger sequencing, and identification services, such as 16S rRNA analysis.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Oligonucleotide Synthesis Market Outlook will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 43.1% in 2025.
Horizon Databook has segmented the Italy oligonucleotide synthesis market based on oligonucleotides, equipment/synthesizer, reagents, services covering the revenue growth of each sub-segment from 2021 to 2033.
. The same source stated that R&D investments in biotechnology sector involves 13,277 employees in biotech research. Hence, the increasing research investments and initiatives in the country are anticipated to boost the demand for advanced oligonucleotide synthesis for research applications.
In addition, key players in this market are adopting various strategies, which are expected to support market growth. For instance, in February 2022, Macrogen Europe BV opened the Milan Genome Center in Italy. This center is focused on oligo synthesis, microsatellite analysis, Sanger sequencing, and identification services, such as 16S rRNA analysis.
Italy Oligonucleotide Synthesis Market Product Outlook (Revenue, USD Million , 2021-2033)
Oligonucleotides
Equipment/Synthesizer
Reagents
Services
Italy Oligonucleotide Synthesis Market Application Outlook (Revenue, USD Million , 2021-2033)
PCR Primers
PCR Assays and Panels
Sequencing
DNA Microarrays
Fluorescence In Situ Hybridization (FISH)
Antisense Oligonucleotides
Other Applications
Italy Oligonucleotide Synthesis Market End Use Outlook (Revenue, USD Million , 2021-2033)
Academic Research Institutes
Diagnostic Laboratories
Pharmaceutical - Biotechnology Companies
Reasons to subscribe to Oligonucleotide Synthesis Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Oligonucleotide Synthesis Market Outlook databook
Our clientele includes a mix of Oligonucleotide Synthesis Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy Oligonucleotide Synthesis Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Italy Oligonucleotide Synthesis Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.